Development of a bioconjugations for carrying the MT29 molecule for the treatment ...
Development of the miR-29c (miR-MT29) for the treatment of skeletal muscle atrophy
Development of MT-02: Oligonucleotide Aimed at the Treatment of Sarcopenia
Development of the miR-29c (miR-MT29) for the treatment of skeletal muscle atrophy
Role of tumor-derived microRNAs in inducing muscle mass loss in patients with Canc...
Molecular, transcriptomic, proteomic and metabolomic aspects of caquexia in a pre-...
Superexpression of miR-29c as a potential treatment of skeletal muscular atrophy i...